E-mail this story

MedImmune creating drug pipeline for AstraZeneca

When Gail Folena-Wasserman joined Gaithersburg biotechnology startup MedImmune in 1991, she was its first employee in research and development, and dreamed of what the company might be "when it grew up."

By Scott Dance, The Baltimore Sun

November 18, 2012

Send to (as many as 3 e-mail addresses, separated by commas):

Send me a copy.

From:

200 characters remaining